Header Logo

Connection

JOHN R STROEHLEIN to Esophagogastric Junction

Back to Details
This is a "connection" page, showing publications JOHN R STROEHLEIN has written about Esophagogastric Junction.
JOHN R STROEHLEIN
Connection Strength
0.010
Esophagogastric Junction
  1. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas. Cancer Treat Rep. 1982 Aug; 66(8):1613-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.